25 Participants Needed

Gastric vs Transpyloric Feeding for Bronchopulmonary Dysplasia

Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Le Bonheur Children's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Gastric feeding, Transpyloric feeding for Bronchopulmonary Dysplasia?

Research shows that feeding into the small bowel (transpyloric feeding) is often recommended to improve nutrient delivery for critically ill patients, which might help reduce complications. However, studies have not consistently shown clear benefits of transpyloric feeding over gastric feeding in terms of growth or reducing complications in infants, and current evidence does not support routine use of transpyloric feeding in critically ill patients.12345

Is transpyloric feeding safe for infants?

Transpyloric feeding in infants, especially those with low birth weight, has been associated with more complications compared to other feeding methods like nasogastric feeding. While it may offer some benefits like reduced risk of aspiration (breathing in food or liquid) and faster weight gain, it also involves greater risks and costs, making it less recommended as a routine feeding method.23678

How does gastric vs transpyloric feeding treatment differ for bronchopulmonary dysplasia?

Gastric and transpyloric feeding differ in the route of administration; gastric feeding delivers nutrients directly to the stomach, while transpyloric feeding bypasses the stomach and delivers nutrients directly to the small intestine. This can be beneficial in reducing the risk of aspiration (inhaling food into the lungs) and may lead to more rapid weight gain in preterm infants, although it may also come with more complications.12679

What is the purpose of this trial?

Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode. Respiratory status will be assessed to determine the optimal feeding mode for each infant.

Research Team

MW

Mark Weems, MD

Principal Investigator

University of Tennessee

Eligibility Criteria

This trial is for hospitalized infants with severe bronchopulmonary dysplasia (BPD) who are experiencing feeding intolerance. The study requires a crossover, meaning each infant will try both feeding methods for two weeks each.

Inclusion Criteria

I was born before reaching 32 weeks of pregnancy.
Currently admitted to the Le Bonheur NICU
I experience frequent heartburn, coughing after eating, or trouble with feeding.
See 1 more

Exclusion Criteria

I have a feeding tube or will get one in the next 8 weeks.
Expected to remain hospitalized less than 8 weeks
Known gastrointestinal anomalies
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomized to 2 weeks of continuous gastric feeding or continuous transpyloric feeding, followed by a crossover to the other feeding mode for an additional 4 weeks.

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Gastric feeding
  • Transpyloric feeding
Trial Overview The study is testing continuous gastric feeding against continuous transpyloric feeding in these infants to see which method better supports their respiratory status and overall health during a four-week period.
Participant Groups
2Treatment groups
Active Control
Group I: Gastric feedingActive Control1 Intervention
Subject will receive 2 weeks of continuous gastric feeding via a feeding tube in the stomach.
Group II: Transpyloric feedingActive Control1 Intervention
Subject will receive 2 weeks of continuous transypyloric feeding via a feeding tube that passes through the stomach into the first portion of the small intestine.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Le Bonheur Children's Hospital

Lead Sponsor

Trials
29
Recruited
5,021,000+

Findings from Research

Transpyloric feeding (TPF) significantly reduces the incidence of ventilator-associated pneumonia in severe traumatic brain injury (TBI) patients compared to gastric feeding (GF), with an odds ratio of 0.3, indicating a strong protective effect.
Patients receiving TPF also had better nutritional intake and fewer gastrointestinal complications, suggesting that TPF is not only safer but also more effective in delivering enteral nutrition in this patient population.
Gastric versus transpyloric feeding in severe traumatic brain injury: a prospective, randomized trial.Acosta-Escribano, J., Fernández-Vivas, M., Grau Carmona, T., et al.[2021]
In a study involving 43 infants weighing under 1400 g, transpyloric feeding was associated with more complications and did not show any benefits in growth rate or nutritional indices compared to other feeding methods.
Bolus and continuous nasogastric feeding methods are recommended as better routine practices for low birth weight infants, as they resulted in fewer complications.
Randomised trial of continuous nasogastric, bolus nasogastric, and transpyloric feeding in infants of birth weight under 1400 g.Macdonald, PD., Skeoch, CH., Carse, H., et al.[2019]
Transpyloric feeding in preterm infants was associated with a higher risk of gastrointestinal disturbances and increased mortality compared to gastric feeding, indicating potential safety concerns.
The systematic review of eight trials found no evidence that transpyloric feeding improved growth or development in preterm infants, suggesting it is not a beneficial feeding method.
Systematic review of transpyloric versus gastric tube feeding for preterm infants.McGuire, W., McEwan, P.[2019]

References

Gastric versus transpyloric feeding in severe traumatic brain injury: a prospective, randomized trial. [2021]
Randomised trial of continuous nasogastric, bolus nasogastric, and transpyloric feeding in infants of birth weight under 1400 g. [2019]
Systematic review of transpyloric versus gastric tube feeding for preterm infants. [2019]
Individualising care in severe bronchopulmonary dysplasia: a series of N-of-1 trials comparing transpyloric and gastric feeding. [2021]
Gastric versus postpyloric feeding. [2007]
Risk-Benefit Profile of Gastric vs Transpyloric Feeding in Mechanically Ventilated Patients: A Meta-Analysis. [2016]
Transpyloric feeding in small preterm infants. [2019]
Controlled study of transpyloric and intermittent gavage feeding in the small preterm infant. [2007]
Equal aspiration rates in gastrically and transpylorically fed critically ill patients. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security